$ADXN insider trading

Over the last 12 months, Addex Therapeutics insiders reported no purchases and 7 sales totaling — across SEC Form 4 filings.

7
7
0%
Side
$1K$10K$100K$1.0M$10Mno $Aug '26Sep
Kalinichev Mikhail
Nunn Jason Raleigh
Mills Roger
Manke Isaac
Lawton Vincent Michael

All insider trades

Scroll the table sideways for price, value and marks.

Sep 2, 2026Kalinichev Mikhail▽ Sale to issuer306,765-100%
Sep 2, 2026Nunn Jason Raleigh▽ Sale to issuer219,561-100%
Sep 2, 2026Mills Roger▽ Sale to issuer392,837-50%
Sep 2, 2026Manke Isaac▽ Sale to issuer219,561-100%
Sep 2, 2026Lawton Vincent Michael▽ Sale to issuer2,507,487-100%
Sep 2, 2026Hill Raymond George▽ Sale to issuer1,365,532-100%
Sep 2, 2026Dyer Timothy Mark▽ Sale to issuer16,413,787-97.4%

Every $ADXN filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Addex Therapeutics filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ADXN feed.

ADXN Insider Trading — Addex Therapeutics Form 4 Buys & Sells | alphai